PEPTIDE CANCER VACCINE MARKET ANALYSIS

Peptide Cancer Vaccine Market, by Pipeline Phase (Research, Preclinical, Phase-I, Phase-I/II, Phase-II, and Phase III), by Application (Colorectal Cancer, Lung Cancer, Pancreatic Cancer, Gastric Cancer, Prostate Cancer, and Breast Cancer), and by Region - Global Insights, Industry Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Sep 2024
Code : CMI1634
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

Global Peptide Cancer Vaccine Market - Competitive Analysis

Major players operating in the global peptide cancer vaccine market include, TapImmune, Merck, BrightPath Biotherapeutics, Sellas, BioLife Science, Boston Biomedical, VAXON Biotech, Lytix Biopharma, ISA Pharmaceuticals, Generex Biotechnology, OncoTherapy Science, Enzo Life Science, Antigen Express, Immatics Biotechnologies, Immatics, Immune Design, Immunomedics, Galena Biopharma, Generex Biotechnology Corporation, and Ultimovacs.